Pharmacological stability of ozone-activated platelet-rich plasma

Authors

  • Reynier Ramírez Suarez Universidad de Ciencias Médicas de Camagüey, Hospital Universitario Manuel Ascunce Domenech
  • Lidyce Quesada Leyva Universidad de Ciencias Médicas de Camagüey, Centro de Inmunología y Productos Biológicos
  • Elizabeth Nicolau Pestana Universidad de Ciencias Médicas de Camagüey, Centro de Inmunología y Productos Biológicos
  • Gretel Mosquera Betancourt Universidad de Ciencias Médicas de Camagüey, Hospital Universitario Manuel Ascunce Domenech

Abstract

Introduction: Pharmacological stability studies allow us to know the ability of a product to maintain over a period of time the integrity of its physicochemical and biological properties, necessary to meet the desired effect and quality guarantees.

Objective: To evaluate the stability of ozone-activated platelet-rich plasma and stress conditions.

Methods: A stability study was designed according to the standards of the State Center for Medicines, to evaluate the main physicochemical and biological properties of ozone-activated platelet-rich plasma. The tests were performed with a test frequency at hours 0, 4, 8 and 12; at 37 ºC, 4 ºC and room temperature.

Results: The pH values showed non-significant changes without exceeding the normal ranges established for this variable (p ≥ 0,05). The concentration of platelets showed a tendency to decrease as the hours increased, at room temperature was where there was less difference; The p-values ≥ 0,05 allowed us to affirm that the concentration of platelets in the batches did not have a statistically significant variation. There were non-significant variations in terms of growth in the samples with respect to temperature (p=0,174). There were no variations in organoleptic characteristics and volume.

Conclusions: Pharmacological stability study of ozone-activated platelet-rich plasma recommend its use in clinical intervention studies especially in the first four hours of combination.

Downloads

Download data is not yet available.

Published

2025-05-04

How to Cite

1.
Ramírez Suarez R, Quesada Leyva L, Nicolau Pestana E, Mosquera Betancourt G. Pharmacological stability of ozone-activated platelet-rich plasma. Rev Cubana Hematol Inmunol Hemoter [Internet]. 2025 May 4 [cited 2025 May 9];41. Available from: https://revhematologia.sld.cu/index.php/hih/article/view/2162

Issue

Section

MEDICINA REGENERATIVA